STOCK TITAN

[Form 4] Lifevantage Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Alissa Neufeld, who identifies her role as General Counsel of Lifevantage Corp (LFVN), reported a sale of 1,283 shares of the company's common stock on 10/01/2025 at a reported price of $9.56 per share. After the transaction the filing shows Ms. Neufeld beneficially owns 116,977 shares. The Form 4 is signed and dated 10/03/2025, indicating timely disclosure under Section 16 reporting requirements.

Alissa Neufeld, che indica nel suo ruolo Consigliere legale generale di Lifevantage Corp (LFVN), ha riportato una vendita di 1.283 azioni ordinarie dell'azienda in data 01/10/2025 al prezzo riportato di 9,56 $ per azione. Dopo l'operazione, la dichiarazione mostra che la signora Neufeld detiene favorevolmente 116.977 azioni. Il Modulo 4 è firmato e datato 03/10/2025, indicando una divulgazione tempestiva conforme alle norme di presentazione della Sezione 16.

Alissa Neufeld, quien identifica su rol como Asesora General de Lifevantage Corp (LFVN), reportó la venta de 1.283 acciones comunes de la empresa en la fecha 01/10/2025 a un precio reportado de $9,56 por acción. Después de la operación, el archivo muestra que la Sra. Neufeld posee beneficiosamente 116.977 acciones. El Formulario 4 está firmado y fechado el 03/10/2025, lo que indica una divulgación oportuna bajo los requisitos de reportes de la Sección 16.

알리사 노이펠드는 Lifevantage Corp(LFVN)의 총괄 법무담당 책임자로 자신을 밝히며, 회사 보통주의 1,283주2025년 10월 1일주당 9.56달러의 보고 가격으로 매도했다고 보고했습니다. 거래 후 제출 서류에 따르면 노이펠드씨는 유리하게 116,977주를 보유하고 있습니다. 양식 4는 2025년 10월 3일에 서명 및 날짜가 기재되어 있으며 섹션 16 보고 요건에 따른 시의적절한 공시를 나타냅니다.

Alissa Neufeld, qui se définit comme conseillère générale de Lifevantage Corp (LFVN), a déclaré la vente de 1 283 actions ordinaires de la société le 01/10/2025 à un prix affiché de 9,56 $ par action. Après la transaction, le formulaire indique que Mme Neufeld détient bénéficiairement 116 977 actions. Le formulaire 4 est signé et daté du 03/10/2025, indiquant une divulgation opportuniste conforme aux exigences de la Section 16.

Alissa Neufeld, die sich in ihrer Rolle als General Counsel von Lifevantage Corp (LFVN) bezeichnet, meldete den Verkauf von 1.283 Aktien der Stammaktien des Unternehmens am 01.10.2025 zu einem angegebenen Preis von 9,56 $ pro Aktie. Nach der Transaktion zeigt die Einreichung, dass Frau Neufeld vorteilhaft 116.977 Aktien besitzt. Das Formular 4 ist am 03.10.2025 unterschrieben und datiert, was eine rechtzeitige Offenlegung gemäß den Berichtsanforderungen der Section 16 anzeigt.

أليسا نيوفيلد، التي تعرف دورها بأنها المستشار العام في Lifevantage Corp (LFVN)، أشارت إلى بيع 1,283 سهماً من أسهم الشركة العادية في 01/10/2025 بسعر مُبلغ عنه قدره 9.56 $ للسهم الواحد. بعد الصفقة، يظهر الملف أن السيدة نيوفيلد تملك بشكل منفعت 116,977 سهماً. النموذج 4 موقع ومؤرخ في 03/10/2025، مما يشير إلى الكشف في الوقت المناسب وفق متطلبات الإبلاغ وفق القسم 16.

阿利莎·诺伊菲尔德,自称 Lifevantage Corp (LFVN) 的总法律顾问,报告在2025/10/01以每股约定价格 $9.56出售了公司的普通股1,283股。交易后,备案显示诺伊菲尔德女士持有有益的116,977股股份。 Form 4在2025/10/03签字并注明日期,表明符合第16条报告要求的及时披露。

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Officer sale of 1,283 shares at $9.56 reduces insider holdings to 116,977 shares and is reported on Form 4.

The filing documents a routine Section 16 disclosure by the company's General Counsel. The sale is labeled with transaction code F, which denotes a disposition, and the Form 4 is signed on 10/03/2025. This satisfies the requirement to report changes in beneficial ownership.

Because the filing contains a single, explicit transaction, it has limited immediate material impact on the company's capital structure. The record provides clear figures for the number sold, price, and remaining beneficial ownership which investors and compliance teams can verify.

Alissa Neufeld, che indica nel suo ruolo Consigliere legale generale di Lifevantage Corp (LFVN), ha riportato una vendita di 1.283 azioni ordinarie dell'azienda in data 01/10/2025 al prezzo riportato di 9,56 $ per azione. Dopo l'operazione, la dichiarazione mostra che la signora Neufeld detiene favorevolmente 116.977 azioni. Il Modulo 4 è firmato e datato 03/10/2025, indicando una divulgazione tempestiva conforme alle norme di presentazione della Sezione 16.

Alissa Neufeld, quien identifica su rol como Asesora General de Lifevantage Corp (LFVN), reportó la venta de 1.283 acciones comunes de la empresa en la fecha 01/10/2025 a un precio reportado de $9,56 por acción. Después de la operación, el archivo muestra que la Sra. Neufeld posee beneficiosamente 116.977 acciones. El Formulario 4 está firmado y fechado el 03/10/2025, lo que indica una divulgación oportuna bajo los requisitos de reportes de la Sección 16.

알리사 노이펠드는 Lifevantage Corp(LFVN)의 총괄 법무담당 책임자로 자신을 밝히며, 회사 보통주의 1,283주2025년 10월 1일주당 9.56달러의 보고 가격으로 매도했다고 보고했습니다. 거래 후 제출 서류에 따르면 노이펠드씨는 유리하게 116,977주를 보유하고 있습니다. 양식 4는 2025년 10월 3일에 서명 및 날짜가 기재되어 있으며 섹션 16 보고 요건에 따른 시의적절한 공시를 나타냅니다.

Alissa Neufeld, qui se définit comme conseillère générale de Lifevantage Corp (LFVN), a déclaré la vente de 1 283 actions ordinaires de la société le 01/10/2025 à un prix affiché de 9,56 $ par action. Après la transaction, le formulaire indique que Mme Neufeld détient bénéficiairement 116 977 actions. Le formulaire 4 est signé et daté du 03/10/2025, indiquant une divulgation opportuniste conforme aux exigences de la Section 16.

Alissa Neufeld, die sich in ihrer Rolle als General Counsel von Lifevantage Corp (LFVN) bezeichnet, meldete den Verkauf von 1.283 Aktien der Stammaktien des Unternehmens am 01.10.2025 zu einem angegebenen Preis von 9,56 $ pro Aktie. Nach der Transaktion zeigt die Einreichung, dass Frau Neufeld vorteilhaft 116.977 Aktien besitzt. Das Formular 4 ist am 03.10.2025 unterschrieben und datiert, was eine rechtzeitige Offenlegung gemäß den Berichtsanforderungen der Section 16 anzeigt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Neufeld Alissa

(Last) (First) (Middle)
3300 TRIUMPH BLVD, SUITE 700

(Street)
LEHI UT 84043

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 F 1,283 D $9.56 116,977 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Alissa Neufeld 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Lifevantage (LFVN) reporting person Alissa Neufeld do?

Alissa Neufeld, listed as General Counsel, sold 1,283 shares of common stock on 10/01/2025 at $9.56 per share.

How many Lifevantage shares does Alissa Neufeld own after the sale?

The Form 4 reports Ms. Neufeld beneficially owns 116,977 shares following the reported transaction.

When was the Form 4 signed and filed?

The Form 4 is signed by Ms. Neufeld on 10/03/2025, disclosing the transaction dated 10/01/2025.

What transaction code is used and what does it mean?

The filing shows transaction code F, which in Form 4 usage denotes a disposition of securities.

Does the filing indicate joint filing or multiple reporting persons?

The filing is marked as by one reporting person (single filer).
Lifevantage Corp

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data

120.69M
10.54M
16.79%
65.65%
19.95%
Packaged Foods
Pharmaceutical Preparations
Link
United States
LEHI